Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 80, Issue 9, Pages 1137-1146
Publisher
BMJ
Online
2021-05-29
DOI
10.1136/annrheumdis-2021-220418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Global research collaboration in a pandemic-challenges and opportunities
- (2021) Philip C. Robinson et al. CURRENT OPINION IN RHEUMATOLOGY
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
- (2021) Martin Schäfer et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 and rheumatoid arthritis
- (2021) Kristin M. D'Silva et al. CURRENT OPINION IN RHEUMATOLOGY
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance
- (2020) Zachary S Wallace et al. RHEUMATOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice
- (2020) Jean W Liew et al. RHEUMATOLOGY
- Perspectives of patients with rheumatic diseases in the early phase of COVID‐19
- (2020) Anna Antony et al. ARTHRITIS CARE & RESEARCH
- Attitudes and Behaviors of Patients With Rheumatic Diseases During the Early Stages of the COVID-19 Outbreak
- (2020) Margaret H.Y. Ma et al. JOURNAL OF RHEUMATOLOGY
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
- (2020) Ted R. Mikuls et al. Arthritis & Rheumatology
- Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry
- (2020) Milena A. Gianfrancesco et al. Arthritis & Rheumatology
- A comprehensive review of rituximab therapy in rheumatoid arthritis patients
- (2019) Soheil Tavakolpour et al. CLINICAL RHEUMATOLOGY
- Safety issues and concerns of new immunomodulators in rheumatology
- (2014) Carlo Selmi et al. Expert Opinion On Drug Safety
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More